Q32 Bio (QTTB) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Q32 Bio (QTTB) is Neutral.

The composite score behind that read is -0.18, weighing +0.12 of bullish evidence against -0.31 bearish.

Q32 Bio last closed at $8.11, -3.11% on the session.

Against the IVW growth benchmark the position is -3.72% over the forecast window.

The read is built from 12 underlying insights — 4 bullish and 8 bearish.

Agreement across those insights is 67%.

Q32 Bio has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Q32 Bio in the 98th percentile on valuation and the 95th percentile on return on equity, where 100 is best.

Q32 Bio is classified under Health Care / Biotechnology, with a market capitalisation of $249.17M.

StockMap tracks Q32 Bio as the 225th largest of the 365 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 190 Moderate Underperform, 164 Neutral and 11 Strong Underperform.

On that composite Q32 Bio ranks 151st of 365 in the group, against a group median of -0.21.